biote Corp. (NASDAQ:BTMD - Get Free Report) major shareholder Guines Llc purchased 6,874 shares of the firm's stock in a transaction on Thursday, April 17th. The stock was bought at an average price of $3.29 per share, for a total transaction of $22,615.46. Following the purchase, the insider now owns 4,164,300 shares in the company, valued at approximately $13,700,547. This represents a 0.17 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.
Guines Llc also recently made the following trade(s):
- On Wednesday, April 9th, Guines Llc bought 13,532 shares of biote stock. The stock was purchased at an average cost of $3.21 per share, for a total transaction of $43,437.72.
- On Monday, April 7th, Guines Llc purchased 43,378 shares of biote stock. The shares were purchased at an average cost of $3.15 per share, with a total value of $136,640.70.
- On Thursday, April 3rd, Guines Llc acquired 7,321 shares of biote stock. The stock was purchased at an average cost of $3.24 per share, for a total transaction of $23,720.04.
- On Monday, March 31st, Guines Llc bought 106,000 shares of biote stock. The shares were purchased at an average price of $3.32 per share, with a total value of $351,920.00.
- On Monday, March 17th, Guines Llc purchased 100 shares of biote stock. The stock was acquired at an average price of $3.74 per share, for a total transaction of $374.00.
- On Thursday, March 13th, Guines Llc acquired 750,000 shares of biote stock. The shares were acquired at an average price of $3.22 per share, with a total value of $2,415,000.00.
biote Price Performance
NASDAQ:BTMD opened at $3.30 on Friday. The firm has a market capitalization of $180.54 million, a price-to-earnings ratio of 12.69 and a beta of 1.17. The business has a 50 day simple moving average of $3.92 and a 200-day simple moving average of $5.12. biote Corp. has a 1 year low of $3.04 and a 1 year high of $8.44.
Institutional Trading of biote
Institutional investors have recently bought and sold shares of the stock. Price T Rowe Associates Inc. MD purchased a new stake in shares of biote in the fourth quarter valued at $67,000. Commonwealth Equity Services LLC bought a new position in biote during the 4th quarter valued at about $68,000. Public Employees Retirement System of Ohio purchased a new stake in biote in the 4th quarter worth about $69,000. Intech Investment Management LLC purchased a new position in shares of biote during the fourth quarter valued at approximately $71,000. Finally, SG Americas Securities LLC bought a new position in shares of biote during the fourth quarter valued at approximately $76,000. 21.68% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Separately, Craig Hallum decreased their target price on shares of biote from $12.00 to $8.00 and set a "buy" rating on the stock in a research report on Thursday, March 13th.
View Our Latest Stock Report on BTMD
biote Company Profile
(
Get Free Report)
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
